International Trade Bulletin - Volume 1, Issue 12
Client Alert | 1 min read | 08.22.06
Inside this issue:
- EUROPE IN THE SPOTLIGHT
- EXPORT CONTROL IN THE SPOTLIGHT
- SECTION 337: Today's Trade Remedy of Choice?
- RUSSIA: Will Nonproliferation Sanctions on Russian Companies Draw Retaliation?
- ANTI-DUMPING: WTO Closes Door on U.S. Zeroing Practice
- CUSTOMS: The U.S. has announced its decision to appeal the recent WTO ruling concerning non-uniform application of the EU's customs administration
- AVIATION: U.S. and EU Renew their Commitment to Open Skies After DOT Delays Its Controversial Foreign Control Rule
- MARKET ACCESS: After Doha : Practical Approaches for Cutting the Costs of Trade
Contacts
Insights
Client Alert | 2 min read | 09.18.25
On September 9, 2025, the U.S. Department of Health and Human Services (HHS) and the Food and Drug Administration (HHS) issued a news release announcing an “aggressive[]” “crackdown” on direct-to-consumer pharmaceutical advertising. This release came on the heels of a Presidential Memorandum President Trump issued the same day directing HHS to “ensure transparency and accuracy in direct-to-consumer prescription drug advertisements,” and the FDA to “take action to enforce legal requirements that advertisements for prescription drugs be truthful and not misleading.”
Client Alert | 3 min read | 09.17.25
Client Alert | 4 min read | 09.17.25
Client Alert | 5 min read | 09.16.25
Bucking the Odds: Why Technology Companies Should Embrace Software Patents Today
